High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells

Overview
Pfizer describes an automated, fully contained cytokine release assay using primary human CD4+ T cells, screening up to 15,000 compounds weekly. Isolated T cells expand 6- to 8-fold in 7 days. G-Rex® 10 open-system flasks (Wilson Wolf) supply the 4-day expansion step of the protocol.
What this paper found
A fully contained, automated cytokine release assay using primary human CD4+ T cells was built to support medium- to high-throughput compound screening. Purchased CD4+ T cells are activated with anti-CD3/CD28 beads for 3 days, then expanded in a G-Rex® 10 flask to reach a 6- to 8-fold increase by day 7. One vial of 1.5E7 cells supplies roughly 3,000 assay wells. Cells are dispensed at 30,000 per well into 384-well plates with compound, restimulated with ImmunoCult, and IL-2 in the supernatant is read by HTRF after 20 to 24 hours. The assay generated more than 5,600 IC50 curves and 11,000 single-dose datapoints with Z primes above 0.2, and supported discovery of an ITK inhibitor clinical candidate.
Note: The assay is phenotypic, so the authors recommend an orthogonal assay to confirm target specificity.
One vial of CD4 [+] T cells therefore enables the screening of 3000 single-dose compounds or 125 11-point dose-response curves in duplicate per expansion. — Amy L. Brault, Theresa A. Dickinson, Mary Ellen Banker, Ruth F. Sommese, Fabien Vincent, SLAS Discovery
Study details
- Authors
- Amy L. Brault, Theresa A. Dickinson, Mary Ellen Banker, Ruth F. Sommese, Fabien Vincent
- Institution
- Discovery Biology and Pharmacology, Pfizer, Groton, CT, USA
- Journal
- SLAS Discovery
- Year
- 2026
- PMID / PMC
- PMID: 41871780
- G-Rex® model(s)
- G-Rex®10
- Cell type(s)
- T-Cells
- Application area
- Autoimmune
- Study phase
- Preclinical
How G-Rex® was used
After 3 days of activation with anti-CD3/CD28 Dynabeads in 24-well plates at 1 million cells/mL, beads are removed magnetically. Cells are diluted to 5×10^5 cells/mL in T cell expansion medium and placed in a G-Rex® 10 flask, with the total volume brought to 40 mL. They are incubated a further 4 days at 37 °C and 5% CO2, giving 7 days in culture in total. A 6 to 8-fold expansion in CD4+ T cell number is expected, and the expanded cells are then used in the IL-2 release assay.
Explore related
Full citation
Brault AL, Dickinson TA, Banker ME, Sommese RF, Vincent F. High throughput, automated and fully contained cytokine release assay using primary human CD4+ T cells. SLAS Discov. 2026;41:100305.
Building a similar workflow?
Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.